Literature DB >> 19733000

How does each substituent functional group of oseltamivir lose its activity against virulent H5N1 influenza mutants?

Thanyada Rungrotmongkol1, Thanyarat Udommaneethanakit, Maturos Malaisree, Nadtanet Nunthaboot, Pathumwadee Intharathep, Pornthep Sompornpisut, Supot Hannongbua.   

Abstract

To reveal the source of oseltamivir-resistance in influenza (A/H5N1) mutants, the drug-target interactions at each functional group were investigated using MD/LIE simulations. Oseltamivir in the H274Y mutation primarily loses the electrostatic and the vdW interaction energies at the -NH(3)(+) and -OCHEt(2) moieties corresponding to the weakened hydrogen-bonds and changed distances to N1 residues. Differentially, the N294S mutation showed small changes of binding energies and intermolecular interactions. Interestingly, the presence of different conformations of E276 positioned between the -OCHEt(2) group and the mutated residue is likely to play an important role in oseltamivir-resistant identification. In the H274Y mutant, it moves towards the -OCHEt(2) group leading to a reduction in hydrophobicity and pocket size, whilst in the N294S mutant it acts as the hydrogen network center bridging with R224 and the mutated residue S294. The molecular details have answered a question of how the H274Y and N294S mutations confer the high- and medium-level of oseltamivir-resistance to H5N1.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19733000     DOI: 10.1016/j.bpc.2009.08.006

Source DB:  PubMed          Journal:  Biophys Chem        ISSN: 0301-4622            Impact factor:   2.352


  7 in total

1.  A 3D-RISM/RISM study of the oseltamivir binding efficiency with the wild-type and resistance-associated mutant forms of the viral influenza B neuraminidase.

Authors:  Jiraphorn Phanich; Thanyada Rungrotmongkol; Daniel Sindhikara; Saree Phongphanphanee; Norio Yoshida; Fumio Hirata; Nawee Kungwan; Supot Hannongbua
Journal:  Protein Sci       Date:  2015-06-22       Impact factor: 6.725

2.  Source of oseltamivir resistance due to single E119D and double E119D/H274Y mutations in pdm09H1N1 influenza neuraminidase.

Authors:  Chonnikan Hanpaibool; Matina Leelawiwat; Kaito Takahashi; Thanyada Rungrotmongkol
Journal:  J Comput Aided Mol Des       Date:  2019-11-26       Impact factor: 3.686

3.  The significance of naturally occurring neuraminidase quasispecies of H5N1 avian influenza virus on resistance to oseltamivir: a point of concern.

Authors:  Nalini Schaduangrat; Jiraphorn Phanich; Thanyada Rungrotmongkol; Hatairat Lerdsamran; Pilaipan Puthavathana; Sukathida Ubol
Journal:  J Gen Virol       Date:  2016-03-02       Impact factor: 3.891

4.  In silico analysis of drug-resistant mutant of neuraminidase (N294S) against oseltamivir.

Authors:  V Karthick; V Shanthi; R Rajasekaran; K Ramanathan
Journal:  Protoplasma       Date:  2012-03-06       Impact factor: 3.356

5.  Receptor recognition mechanism of human influenza A H1N1 (1918), avian influenza A H5N1 (2004), and pandemic H1N1 (2009) neuraminidase.

Authors:  Nipa Jongkon; Chak Sangma
Journal:  J Mol Model       Date:  2011-04-27       Impact factor: 1.810

6.  Quantitative predictions of binding free energy changes in drug-resistant influenza neuraminidase.

Authors:  Daniel R Ripoll; Ilja V Khavrutskii; Sidhartha Chaudhury; Jin Liu; Robert A Kuschner; Anders Wallqvist; Jaques Reifman
Journal:  PLoS Comput Biol       Date:  2012-08-30       Impact factor: 4.475

7.  Virtual screening for oseltamivir-resistant a (H5N1) influenza neuraminidase from traditional Chinese medicine database: a combined molecular docking with molecular dynamics approach.

Authors:  Vasudevan Karthick; Karuppasamy Ramanathan
Journal:  Springerplus       Date:  2013-03-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.